comparemela.com

Latest Breaking News On - Exela pharma sciences - Page 1 : comparemela.com

Global Super Generics Market Report 2024: A $200 Billion

Dublin, May 30, 2024 (GLOBE NEWSWIRE) The

United statesMayne pharmaKashiv biosciencesTesa labtecHikma pharmaceuticalsRubicon researchTechnology landscapeRoute of administrationTaiwan liposome companyTeva pharmaceuticalExela pharma sciencesIntellipharmaceutics internationalAzurity pharmaceuticalsHarrow healthAscendia pharmaceuticalsLatitude pharmaceuticals

Super Generics Market Size Will Reach USD 128 62 Billion to 2031 - Revealed InsightAce Latest Study

/PRNewswire/ InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Super Generics Market –By Therapeutic Area.

South africaUnited kingdomUnited statesSouth koreaKashiv biosciencesAsia pacificTeva treandaMayne pharmaTesa labtecLatitude pharmaceuticalsRoute of administration intravenousTeva pharmaceuticalAzurity pharmaceuticalsExela pharma sciencesRoute of administrationAccord healthcare inc

Exela Pharma recalls 400K drugs

Exela Pharma Sciences is recalling over 415,000 drug vials due to possible presence of silicone. This includes 8.4% sodium bicarbonate and midazolam.

Exela pharma sciencesPthe fda

Exela Recalls Three Injectable Products Due to Presence of Particulate Matter

Exela Pharma Sciences is recalling 3 injectable products due to the potential presence of particulate matter.

Exela pharma sciencesDrug administration medwatchSodium bicarbonate injectionSodium chloride injectionDrug administration

Specialty injectables maker Exela issues recall after particles turn in up in 3 different drugs

Specialty injectables maker Exela issues recall after particles turn in up in 3 different drugs
fiercepharma.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fiercepharma.com Daily Mail and Mail on Sunday newspapers.

Exela pharma sciencesNorth carolina basedDrug administration

vimarsana © 2020. All Rights Reserved.